Login to Your Account

Freed of A-beta, taus that bind, AD ApoE4 protein target

By Randy Osborne
Staff Writer

Wednesday, July 12, 2017

Topping off a series A round that began in the summer of 2015 with $55 million, E-Scape Bio Inc. raised $63 million in total that CEO Leon Chen told BioWorld should carry the firm into proof-of-concept work.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription